Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Elevance Health (ELV)

Elevance Health elects Steven H. Collis as independent director effective August 1, 2025

Neutral Impact 2 of 5 leadership Written later

Elevance Health's board elected Steven H. Collis, Executive Chairman of Cencora, as an independent director effective August 1, 2025, with a term expiring at the 2027 annual meeting. He was also appointed to the Audit and Finance Committees, and the board determined he qualifies as an audit committee financial expert. The filing describes a routine board addition with no financial figures disclosed.

Key points

  • Steven H. Collis elected by the board on July 28, 2025, effective August 1, 2025
  • Term expires at the Company's 2027 annual meeting of shareholders
  • Appointed to the Audit and Finance Committees; board determined he is an audit committee financial expert
  • Previously president and CEO of Cencora for 13 years, and became Executive Chairman in 2024

The filing

CompanyElevance Health (ELV)
Form8-K, current report
Filed with the SECJul 28, 2025, 4:38 PM ET
Accession number0001156039-25-000118

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.